Temozolomide and radiotherapy in newly diagnosed glioblastoma patients: O6-methylguanine-DNA methyltransferase (MGMT) promotor methylation status and Ki-67 as biomarkers for survival and response to treatment-Reference-Cited by-同舟云学术

Temozolomide and radiotherapy in newly diagnosed glioblastoma patients: O6-methylguanine-DNA methyltransferase (MGMT) promotor methylation status and Ki-67 as biomarkers for survival and response to treatment

Published:2012-03 Issue:3 Volume:11 Page:168-176
ISSN:1610-1979
Container-title:The Chinese-German Journal of Clinical Oncology
language:en
Short-container-title:Chin. -Ger. J. Clin. Oncol.

Author:

Abdel Karim Khaled,El Mahdy M. M.,Abdel Wahab M. M.,Ezz EI Arab L. R.,El Shehaby A.,Abdel Raouf S.

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10330-011-0928-y.pdf

Reference50 articles.

1. Taylor RE. Defining the standard of care for high-grade glioma — NICE deal for patients. Clin Oncol, 2008, 1: 97–98.

2. Lefranc F, Brotchi J, Kiss R. Possible future issues in the treatment of glioblastoma: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol, 2005, 23: 2411–2422.

3. Lefranc F, Sadeghi N, Camby I, et al. Present and potential future issues in glioblastoma treatment. Expert Rev Anticancer Ther, 2006, 6: 719–732.

4. Laperriere N, Zuraw L, Cairncross G. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol, 2002, 64: 259–273.

5. Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet, 2002, 359: 1011–1018.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide;Cochrane Database of Systematic Reviews;2021-03-12

2. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma;Journal of Neuro-Oncology;2020-11

3. MGMT testing allows for personalised therapy in the temozolomide era;Tumor Biology;2015-10-30